Based on the peer investigations of pathogenesis on both schizophrenia and glioma, we have the reason to advise EIF3K as the potential targets of the mechanism study of schizophrenia and glioma, resulting new therapies for both diseases. This evidence concerns the gene EIF3K and glioma.